Cargando…
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials
Amyloid-β (Aβ) plaques and aggregated tau are two core mechanisms that contribute to the clinical deterioration of Alzheimer’s disease (AD). Recently, targeted-Aβ plaque reduction immunotherapies have been explored for their efficacy and safety as AD treatment. This systematic review critically revi...
Autores principales: | Rashad, Areeba, Rasool, Atta, Shaheryar, Muhammad, Sarfraz, Azza, Sarfraz, Zouina, Robles-Velasco, Karla, Cherrez-Ojeda, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818878/ https://www.ncbi.nlm.nih.gov/pubmed/36611492 http://dx.doi.org/10.3390/healthcare11010032 |
Ejemplares similares
-
Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis
por: Zaib, Asma, et al.
Publicado: (2022) -
The Allosteric Antagonist of the Sigma-2 Receptors—Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer’s Disease: A Scoping Systematic Review
por: Rasheed, Anum, et al.
Publicado: (2022) -
Addressing the Endometriosis Knowledge Gap for Improved Clinical Care—A Cross-Sectional Pre- and Post-Educational-Intervention Study among Pakistani Women
por: Saad, Muhammad, et al.
Publicado: (2023) -
SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
por: Ul Amin, Noor, et al.
Publicado: (2022) -
Emerging Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A Systematic Review
por: Farrukh, Shahrukh, et al.
Publicado: (2023)